阿尔茨海默病中β淀粉样蛋白的生成及清除的调节

阿尔茨海默病（Alzheimer’s disease, AD）是一种慢性退行性神经系统疾病,临床主要表现为进行性认知能力下降、记忆力衰退、人格改变等。AD的标志性病理特征包括脑细胞外β淀粉样蛋白（β-amyloid protein,Aβ）沉积形成老年斑、细胞内神经纤维缠结(neurofibrillary tangles,NFT)、神经炎症增加以及神经元凋亡。β淀粉样蛋白主要在神经元产生,是淀粉样前体蛋白经过一系列酶解反应生成的由39～42个氨基酸组成的多肽,调节Aβ的生成和清除能够有效延缓甚至逆转阿尔茨海默病的进程,因而具有重大的研究价值。β-分泌酶（β-site APP cleaving enzyme 1,BACE1）为Aβ产生过程中的关键酶,其含量及活性的改变均能影响Aβ产生,在阿尔茨海默病的发生发展中发挥至关重要的作用;老年斑周围炎性细胞的聚集提示,AD与神经炎症高度相关,神经炎症相关细胞能够参与Aβ的清除,多种炎性因子也能调节Aβ的生成;非编码RNA虽很少直接参与Aβ的产生、沉积和清除,但其可以通过多种途径调节Aβ的产生。本文从β淀粉样蛋白生成及清除的机制着手,重点阐述了BACE1、神经炎症、非编码RNA对Aβ调控的重要作用,以期为AD发病机制的进一步研究提供思路,并对阿尔茨海默病早期干预及治疗提供理论参考。     

不同寡聚形式的Aβ42与细胞膜作用显示毒性差异

β-淀粉样蛋白（β-amyloid peptide, Aβ）与神经细胞膜的相互作用是阿尔茨海默症（Alzheimer’s disease, AD）发病的重要事件,但不同寡聚形式的Aβ与细胞膜相互作用的差异仍缺乏直接比较。本文通过膜天平、透射电子显微镜、Thioflavin T(ThT)和细胞毒性实验等方法,检测Aβ42单体、ADDL、原纤维等形式的β-淀粉样蛋白与磷脂膜的作用方式,分析不同形式淀粉样蛋白对细胞的毒性作用。结果显示,（1）单层膜的实验数据可以判断Aβ42单体和寡聚体插膜能力存在差异,Aβ42单体能插入磷脂单层膜内,而Aβ42 ADDL不具备插膜能力;（2）透射电镜和ThT荧光检测,定性定量地分析出不同聚集形式的Aβ42具有不同的纤维化能力,Aβ42单体纤维化能力最强,而Aβ42原纤维的纤维化能力次之,Aβ42ADDL很难形成纤维;（3）Aβ42单体细胞毒性较弱,而Aβ42 ADDL和原纤维的细胞毒性较强。由以上结果可以得出结论：在磷脂膜存在的条件下,Aβ42单体可以插入膜内并迅速形成无毒性的Aβ42纤维,因此,细胞毒性较弱。而ADDL及原纤维不能插入膜内,纤维化能力较弱,从而以寡聚体的形式发挥细胞毒性。将单体、ADDL及原纤维形式的Aβ42与细胞膜相互作用进行分析,将为Aβ42在AD中的毒性机制研究提供一定的参考。但各种寡聚体入胞的方式及毒性机制仍需要进一步研究。     

铜对秀丽隐杆线虫毒性效应的研究

为了阐明铜(Cu)对秀丽隐杆线虫Caenorhabditis elegans长期作用的毒性效应,对实验室多代筛选的耐铜型秀丽隐杆线虫进行了寿命、衰老、发育、生殖和运动等生物学指标的研究.结果显示耐铜型秀丽隐杆线虫与野生型秀丽隐杆线虫相比其寿命缩短、衰老提前、个体发育受到抑制,且出现繁殖率降低、生殖能力减弱、运动行为存在障碍等一系列生理变化.本文为理解与阐明Cu的毒性效应提供了实验资料,有助于深入开展Cu毒性机理的研究.     

二维纳米材料抗β-淀粉样蛋白治疗阿尔茨海默病

阿尔茨海默病（Alzheimer’s disease, AD）是一种老年人群中高发的进行性神经退行性疾病。β-淀粉样蛋白（β-amyloid,Aβ）假说是目前科学界广泛支持的AD发病机制。清除Aβ、阻止Aβ聚集和解聚Aβ纤维的策略有望给AD的治疗提供有效途径。然而,目前已报道的抗Aβ治疗AD的药物存在的诸多缺点,限制了其临床应用。随着纳米技术的飞速发展,二维纳米材料在医学上的应用逐渐受到研究人员的关注。二维纳米材料不仅理化特性优异,而且生物相容性良好,还易于穿越细胞膜及血脑屏障。近年来研究发现,多种二维纳米材料能通过分子间相互作用力、近红外光热效应、光催化氧化、Cu2 +螯合以及药物负载等机制来抑制Aβ聚集,或使Aβ纤维解聚,在治疗AD方面有着很大的潜力。本文将围绕石墨烯和类石墨烯二维纳米材料,例如二硫化钼、石墨相氮化碳、黑磷等用于抗Aβ治疗AD方面的研究进行综述。     

维生素C通过胰岛素信号通路增强秀丽隐杆线虫抗氧化作用

目的：利用秀丽隐杆线虫为模式生物,研究维生素C在秀丽隐杆线虫体内的抗氧化效应及其机制。方法：分别以含有0.05、0.25、0.5 mg/mL维生素C的NGM培养基饲养秀丽隐杆线虫,测定不同浓度维生素C饲养线虫体内超氧化物歧化酶（SOD）和过氧化氢酶（CAT）的含量,同时检测0.25 mg/mL的维生素C饲养线虫age-1、daf-2、daf-16、sir-2.1、clt-1基因mRNA变化。在高氧环境中,干扰0.25 mg/mL维生素C饲养线虫daf-2、daf-16基因表达检测线虫的存活情况,观察0.25 mg/mL维生素C饲养线虫DAF-16入核情况。结果：0.25 mg/mL的维生素C提高秀丽隐杆线虫体内SOD和CAT活力,在高氧环境中,0.25 mg/mL的维生素C降低age-1、daf-2基因表达,提高daf-16基因表达,同时增加DAF-16蛋白入核。结论：维生素C通过DAF-16胰岛素信号通路增强秀丽隐杆线虫抗氧化作用。     

二甲双胍降低肥胖大鼠海马内PPARγ、IDE表达伴随TNF-α和Aβ42表达上调

二甲双胍（metformin,MET）常用于肥胖胰岛素抵抗患者改善胰岛素抵抗降低血糖,但MET可增加脑内β-淀粉肽（β-amyloid,Aβ）表达,目前机制不清.Aβ沉积作为阿尔茨海默病（Alzheimer's disease, AD)始发病理生理学改变,在AD中发挥重要作用. 为研究MET对脑内Aβ表达的影响及机制,采用饮食诱导肥胖大鼠模型 （OB组）予MET灌胃4 W后（MET组）,观察海马内Aβ42及相关因子肿瘤坏死因子α （TNF-α）、过氧化物酶体增殖物激活受体γ(peroxisome proliferator-activated receptor γ, PPARγ)、胰岛素降解酶（insulin degrading enzyme, IDE）的表达. 结果显示,OB组大鼠血糖水平较对照组（CTL组）无明显差异,胰岛素含量明显升高（P<0.01), 并存在胰岛素抵抗;OB组大鼠海马内TNF-α、 Aβ42 水平较CTL组上调,PPARγ、IDE表达下降(P<0.05). MET组胰岛素及胰岛素抵抗均较OB组降低(P<0.05),海马内TNF-α、Aβ42表达增加(P<0.01);PPARγ,IDE表达较OB组减少(P<0.01). 上述结果提示,二甲双胍作为治疗肥胖胰岛素抵抗的一线用 药,可改善胰岛素抵抗,但增加海马内炎性因子TNF-α表达、减少PPARγ水平,降低其调控IDE转录作用,使IDE表达减少,伴随Aβ42降解减少沉积增加,从而可能增加AD发病风险.     

取代短链脂肪酸对秀丽隐杆线虫的抗氧化作用

短链脂肪酸(short chain fatty acids, SCFAs)是碳原子数为1～6的有机脂肪酸,不但可以作为生物体内能源物质,而且还具有抗炎、影响肠道菌群代谢和预防早发1型糖尿病等重要作用。然而,目前多数是对传统短链脂肪酸的生物学作用进行研究,对取代短链脂肪酸(short branched-chain fatty acids, SBCFAs)的相关研究甚少。本研究以秀丽隐杆线虫为模式动物,系统探究SBCFAs的抗氧化生物活性作用。采用胡桃醌氧化应激模型,在体内评价SBCFAs对秀丽隐杆线虫生存能力的影响,并通过体外抗氧化及H_2DCFDA荧光染色实验,进一步评价SBCFAs清除活性氧自由基(reactive oxygen species,ROS)的能力。本研究证实,在氧化应激研究中,传统脂肪酸不能延长秀丽隐杆线虫的存活时间,而2′-甲基取代短链脂肪酸(n=4-6)具有显著的抗氧化作用。体外抗氧化实验表明,2′-甲基取代短链脂肪酸(n=4-6)不具有体外直接清除ROS的能力,但是H_2DCFDA荧光染色实验显示2′-甲基丁酸能够显著降低线虫体内的ROS水平,表明2′-甲基丁酸通过降低体内ROS水平,从而增强秀丽隐杆线虫的抗氧化应激能力。本研究提示,传统短链脂肪酸不具有抗氧化作用;2′-甲基取代短链脂肪酸(n=4-6)能显著增强秀丽隐杆线虫的抗氧化能力;甲基取代位置和取代烷基长度对短支链脂肪酸的抗氧化作用至关重要,其作用机制需进一步研究。     

β淀粉样蛋白突变体的寡聚及插膜能力鉴定

β-淀粉样蛋白（β-amyloid peptide, Aβ）的插膜与寡聚是导致阿尔茨海默症（Alzheimer disease, AD）发病的重要事件。已有研究证明,Aβ氨基酸序列29～36与1～28依靠“核心疏水簇”（central hydrophobic cluster,CHC）的作用形成一个稳定的β-发夹结构,Aβ1-40/Aβ1-42的插膜与寡聚需要作用于序列37～40/37～42从而解除序列29～36与N-端之间的结合,但各基元序列如何互作从而贡献出Aβ的寡聚及插膜行为仍不清楚。本文主要研究Aβ1-28、Aβ1-36、Aβ1-40、Aβ1-42、Aβ11-42、Aβ17-42等突变体的寡聚和插膜能力,并探讨各基元序列（motif）在突变体插膜与寡聚过程中的相互作用。Western印迹、硫黄素T荧光分析、透射电镜等实验检测寡聚能力,模型膜实验比较插膜能力。结果显示：与Aβ1-28及Aβ1-36相比,Aβ1-42、Aβ11-42及Aβ17-42均具有较强的寡聚及插膜能力,说明C-端序列37～42在Aβ寡聚及插膜过程中具有重要的起始作用;Aβ1-42及Aβ1-40可以形成原纤维及纤维,但Aβ11-42、Aβ17-42却不能,这显示序列1～17可以稳定纤维结构。Aβ1-28及Aβ1-36插膜及寡聚能力弱,暗示这两个突变体可能形成了不容易插膜且不容易寡聚的自身稳定结构。上述结果证明,Aβ蛋白C-端是诱导插膜与寡聚的主因,N-端可以稳定长纤维,但对插膜和寡聚的影响并不大,中间肽段很可能形成一个自身稳定的区域,这在一定程度上解释Aβ基元序列的相互作用,但具体氨基酸互作分子机制及抑制方法还需进一步研究。     

秀丽隐杆线虫模型在阿尔茨海默病研究中的应用

阿尔茨海默病（Alzheimer’s disease,AD）是一种与年龄相关的神经退行性疾病,该疾病的病理特征为老年斑（SPs）和神经原纤维缠结（NFTs）的存在。目前,阿尔茨海默病患病率呈现逐年上升的趋势,寻找完全治愈或延缓阿尔茨海默症发展的有效疗法和药物迫在眉睫。秀丽隐杆线虫（Caenorhabditis elegans）的基因和神经元功能与人类具有高度同源性,可作为研究阿尔茨海默病发病机制研究的较好模型。本文综述AD的发病机制假说、秀丽隐杆线虫AD模型以及线虫模型在AD治疗中的应用进展,旨在为后续研究AD提供理论参考。     

TGF-β1对Aβ1-42诱导海马神经元-小胶质细胞共培养体系中细胞因子表达和分泌的影响

目的：探讨在海马神经元和小胶质细胞共培养体系中转化生长因子-β1（TGF-β1）对β淀粉样肽1-42（Aβ_1-42）诱导的小胶质细胞激活表达和分泌细胞因子的影响。方法：将大鼠海马神经元和小胶质细胞进行共同培养,于共同培养后第5日,加入TGF-β1（5 or 20 ng/ml）,1 h后加入Aβ_1-42（5 μmol/L）,继续培养72 h后用于后续实验,Western blot法检测诱导型一氧化氮合酶（iNOS）的蛋白表达;Real-time PCR和ELISA法检测肿瘤坏死因子-α（TNF-α）、白介素-1β（IL-1β）和胰岛素样生长因子（IGF-1）的mRNA表达和分泌。结果：在共同培养的海马神经元与小胶质细胞体系中,Aβ_1-42诱导炎症因子iNOS、TNF-α和IL-1β的表达和/或分泌上调,神经营养因子IGF-1表达下调,TGF-β1预处理削弱上述Aβ_1-42的作用。结论：TGF-β1明显抑制Aβ_1-42诱导的小胶质细胞激活引起的炎性细胞因子的增加和神经营养因子的减少。     

Protective effect of the xanthate, D609, on Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress in primary neuronal cells

Tricyclodecan-9-yl-xanthogenate (D609) is an inhibitor of phosphatidylcholine-specific phospholipase C, and this agent also has been reported to protect rodents against oxidative damage induced by ionizing radiation. Previously, we showed that D609 mimics glutathione (GSH) functions and that a disulfide is formed upon oxidation of D609 and the resulting dixanthate is a substrate for GSH reductase, regenerating D609. Considerable attention has been focused on increasing the intracellular GSH levels in many diseases, including Alzheimer's disease (AD). Amyloid β-peptide [Aβ(1-42)], elevated in AD brain, is associated with oxidative stress and toxicity. The present study aimed to investigate the protective effects of D609 on Aβ(1-42)-induced oxidative cell toxicity in cultured neurons. Decreased cell survival in neuronal cultures treated with Aβ(1-42) correlated with increased free radical production measured by dichlorofluorescein fluorescence and an increase in protein oxidation (protein carbonyl, 3-nitrotyrosine) and lipid peroxidation (4-hydroxy-2-nonenal) formation. Pretreatment of primary hippocampal cultures with D609 significantly attenuated Aβ(1-42)-induced cytotoxicity, intracellular ROS accumulation, protein oxidation, lipid peroxidation and apoptosis. Methylated D609, with the thiol functionality no longer able to form the disulfide upon oxidation, did not protect neuronal cells against Aβ(1-42)-induced oxidative stress. Our results suggest that D609 exerts protective effects against Aβ(1-42) toxicity by modulating oxidative stress. These results may be of importance for the treatment of AD and other oxidative stress-related diseases.     

Asymmetric dimethylarginine exacerbates Aβ-induced toxicity and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease

Growing evidence suggests a strong association between cardiovascular risk factors and incidence of Alzheimer disease (AD). Asymmetric dimethylarginine (ADMA), the endogenous nitric oxide synthase inhibitor, has been identified as an independent cardiovascular risk factor and is also increased in plasma of patients with AD. However, whether ADMA is involved in the pathogenesis of AD is unknown. In this study, we found that ADMA content was increased in a transgenic Caenorhabditis elegans β-amyloid (Aβ) overexpression model, strain CL2006, and in human SH-SY5Y cells overexpressing the Swedish mutant form of human Aβ precursor protein (APPsw). Moreover, ADMA treatment exacerbated Aβ-induced paralysis and oxidative stress in CL2006 worms and further elevated oxidative stress and Aβ secretion in APPsw cells. Knockdown of type 1 protein arginine N-methyltransferase to reduce ADMA production failed to show a protective effect against Aβ toxicity, but resulted in more paralysis in CL2006 worms as well as increased oxidative stress and Aβ secretion in APPsw cells. However, overexpression of dimethylarginine dimethylaminohydrolase 1 (DDAH1) to promote ADMA degradation significantly attenuated oxidative stress and Aβ secretion in APPsw cells. Collectively, our data support the hypothesis that elevated ADMA contributes to the pathogenesis of AD. Our findings suggest that strategies to increase DDAH1 activity in neuronal cells may be a novel approach to attenuating AD development.     

Assaying ��-amyloid Toxicity using a Transgenic C. elegans Model

Accumulation of the β-amyloid peptide (Aβ) is generally believed to be central to the induction of Alzheimer''s disease, but the relevant mechanism(s) of toxicity are still unclear. Aβ is also deposited intramuscularly in Inclusion Body Myositis, a severe human myopathy. The intensely studied nematode worm Caenorhabditis elegans can be transgenically engineered to express human Aβ. Depending on the tissue or timing of Aβ expression, transgenic worms can have readily measurable phenotypes that serve as a read-out of Aβ toxicity. For example, transgenic worms with pan-neuronal Aβ expression have defects is associative learning (Dosanjh et al. 2009), while transgenic worms with constitutive muscle-specific expression show a progressive, age-dependent paralysis phenotype (Link, 1995; Cohen et al. 2006). One particularly useful C. elegans model employs a temperature-sensitive mutation in the mRNA surveillance system to engineer temperature-inducible muscle expression of an Aβ transgene, resulting in a reproducible paralysis phenotype upon temperature upshift (Link et al. 2003). Treatments that counter Aβ toxicity in this model [e.g., expression of a protective transgene (Hassan et al. 2009) or exposure to Ginkgo biloba extracts (Wu et al. 2006)] reproducibly alter the rate of paralysis induced by temperature upshift of these transgenic worms. Here we describe our protocol for measuring the rate of paralysis in this transgenic C. elegans model, with particular attention to experimental variables that can influence this measurement.     

Green tea aroma fraction reduces β-amyloid peptide-induced toxicity in Caenorhabditis elegans transfected with human β-amyloid minigene

Green tea is a popular world-wide beverage with health benefits that include preventive effects on cancer as well as cardiovascular, liver and Alzheimer’s diseases (AD). This study will examine the preventive effects on AD of a unique aroma of Japanese green tea. First, a transgenic Caenorhabditis elegans (C. elegans) CL4176 expressing human β-amyloid peptide (Aβ) was used as a model of AD. A hexane extract of processed green tea was further fractionated into volatile and non-volatile fractions, named roasty aroma and green tea aroma fractions depending on their aroma, by microscale distillation. Both hexane extract and green tea aroma fraction were found to inhibit Aβ-induced paralysis, while only green tea aroma fraction extended lifespan in CL4176. We also found that green tea aroma fraction has antioxidant activity. This paper indicates that the green tea aroma fraction is an additional component for prevention of AD.     

Tau蛋白寡聚体与阿尔茨海默病

阿尔茨海默病（AD）是严重影响老年人健康的一种神经退行性疾病。AD主要两个病理特征是tau蛋白组成的神经原纤维缠结和β淀粉样蛋白组成的Aβ斑块。Tau蛋白是目前研究AD机制和防治药物的一个重要靶点。Tau蛋白的寡聚体形式被认为是最具神经毒性的,并且其能在神经元之间传播,诱导胞内的正常tau蛋白聚集。本综述结合近年来的文献报道,对tau寡聚体的制备手段、形成机理、神经毒性、传播机制以及治疗前景等方面做了系统总结和讨论,为人们深入认识tau寡聚体提供参考。     

载脂蛋白CⅢ通过氧化应激通路促进人肾小球系膜细胞表型转分化

本研究旨在探讨富含甘油三酯的脂蛋白（triglyceride-rich lipoproteins, TRLs）中载脂蛋白CⅢ（apolipoprotein CⅢ, ApoCⅢ）的高表达对人肾小球系膜细胞（human mesangial cells, HMCs）表型转分化的作用及其机制。从正常野生型小鼠（WT）及ApoCⅢ转基因小鼠血浆中提取TRLs,在体外培养的HMCs中分别给予相同甘油三酯浓度的正常TRLs（TRL-WT）,或富含ApoCⅢ的TRLs（TRL-CⅢ）孵育12 h。结果显示,TRL-CⅢ中ApoCⅢ蛋白质表达水平约为WT小鼠TRLs的4倍。与阴性对照（NC）组相比,两种TRLs均可诱导HMCs中转分化标志物α-SMA及纤维化相关因子纤连蛋白、TGF-β1、CTGF、ColⅠ、Col Ⅳ的mRNA及α-SMA和纤连蛋白的蛋白质表达水平升高,且TRL-CⅢ较TRL-WT作用更明显。TRL-CⅢ组中,α-SMA及纤连蛋白蛋白质表达水平分别为TRL-WT组的1.4倍（P<0.05）和2.1倍（P<0.01）。与NC组相比,两种TRLs均可引起细胞内活性氧（reactive oxygen species, ROS）水平增加,且TRL-CⅢ组较TRL-WT组高1.5倍（P<0.05）;氧化应激相关因子Nox4、P22phox、PKC-β的mRNA及Nox4蛋白表达水平在两组均增高,且TRL-CⅢ较TRL-WT作用更为明显（P<0.05）。TRL-CⅢ组中,Nox4蛋白表达水平为TRL-WT组的1.6倍（P<0.01）。NADPH氧化酶抑制剂apocynin可使TRL-CⅢ引起的细胞内ROS水平下降约2倍（P<0.01）。上述转分化标志物及纤维化相关因子基因及蛋白质表达水平均明显下降。本研究表明,TRLs通过氧化应激通路促进HMCs表型转分化,ApoCⅢ的高表达进一步促进该作用。